Abstract
To examine if appropriate antithrombotic therapy in atrial fibrillation is implemented nationally. Using prescriptions for digoxin as a surrogate for atrial fibrillation, we identified its coprescription with antithrombotic therapy, aspirin or warfarin in a national prescribing database in 27 571 patients over 45 years old. Proportionately significantly more men were on warfarin, and use in those >75 years old was three times less than in those 75 years old least likely to receive warfarin.

This publication has 13 references indexed in Scilit: